ANDA 204968, held by Hec Pharm. Levofloxacin.
As of Nov 16, 2026, ANDA 204968 (Levofloxacin), held by Hec Pharm, was first approved by FDA on Feb 5, 2019, with 1 approved supplement and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Feb 5, 2019 | Original application | Approved | None posted |
| Levofloxacin250MG · tablet;oral | Levofloxacin | Rx |
| Levofloxacin500MG · tablet;oral | Levofloxacin | Rx |
| Levofloxacin750MG · tablet;oral | Levofloxacin | Rx |
| Sep 20, 2024 | Supplement 2Labeling · Standard review | Approved | None posted |
| Feb 5, 2019 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters